<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04526743</url>
  </required_header>
  <id_info>
    <org_study_id>HCB/2019/0090</org_study_id>
    <nct_id>NCT04526743</nct_id>
  </id_info>
  <brief_title>Eating Behavior and Weight Trajectory After Bariatric Surgery</brief_title>
  <acronym>Regain_SEEN</acronym>
  <official_title>Mental Health, Dysfunctional Eating Pattern and Weight Trajectory in Subjects Undergoing Bariatric Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>GOSEEN Obesity group of the Spanish Endocrinology Society</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>GOSEEN Obesity group of the Spanish Endocrinology Society</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Studying the mechanisms of weight regain (WR) may provide much needed insight into sustained&#xD;
      obesity management. The aim of this five-year, prospective, multicenter study is to evaluate&#xD;
      the association among eating patterns (specifically maladaptive behaviors), certain&#xD;
      psychological variables and weight trajectory in the short- and long-term after bariatric&#xD;
      surgery (BS). The study will include 2 groups: 1.- Candidates to primary BS undergoing&#xD;
      laparoscopic gastric bypass (LGBP) or laparoscopic sleeve gastrectomy (LSG) from September&#xD;
      2020 to September 2021. This group will be evaluated prior to surgery, at 4 months, 1 year, 3&#xD;
      years and 5 years after BS, and 2.- a control group of subjects with obesity not candidates&#xD;
      to BS matched with the intervention group for age, sex and BMI prior to BS. They will be&#xD;
      evaluated once. The primary variable will be: body weight: total weight lost (%), excess&#xD;
      weight lost (%), total weight regained (%), excess of weight regain (%). Information&#xD;
      regarding the psychological and behavioral variables will be collected using questionnaires&#xD;
      that have been validated in our setting and will be completed by the patients themselves&#xD;
      online.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The objective of this study is to evaluate the association among eating patterns&#xD;
      (specifically maladaptive behaviors), certain psychological variables and weight trajectory&#xD;
      in the short- and long-term after bariatric surgery.&#xD;
&#xD;
      Design: Five-year, prospective, multicenter study.&#xD;
&#xD;
      The study will include 2 groups:&#xD;
&#xD;
        1. Candidates to primary BS undergoing laparoscopic gastric bypass (LGBP) or laparoscopic&#xD;
           sleeve gastrectomy (LSG) from September 2020 to September 2021.The subjects of this&#xD;
           group will be followed prior to BS, at 4 months, 1 year, 3 years and 5 years after BS.&#xD;
&#xD;
        2. A control group of subjects with obesity not candidates to BS matched with the&#xD;
           intervention group for age, sex and BMI prior to BS. They will be evaluated once.&#xD;
&#xD;
      Inclusion criteria:&#xD;
&#xD;
        -  Candidates to primary BS from 09/2020 to 09/2021.&#xD;
&#xD;
        -  Subjects with obesity (&gt;40 kg/m2) not candidates to BS.&#xD;
&#xD;
        -  Internet users.&#xD;
&#xD;
        -  Primary BS: LGBP and LSG.&#xD;
&#xD;
        -  Accept to participate in the study and provide signed informed consent.&#xD;
&#xD;
      Exclusion criteria:&#xD;
&#xD;
        -  Second time and/or revisional BS.&#xD;
&#xD;
        -  Pregnancy.&#xD;
&#xD;
        -  Presence of intellectual impairment impeding the administration of the psychometric&#xD;
           tools.&#xD;
&#xD;
        -  Type 1 diabetes.&#xD;
&#xD;
        -  Dyslexia. Weight variables: definitions.&#xD;
&#xD;
           a) The different weight variables will be calculated as follows:&#xD;
&#xD;
        -  Weight lost (kg): Pre-BS weight - weight at nadir.&#xD;
&#xD;
        -  Current weight lost: Pre-BS weight - current weight.&#xD;
&#xD;
        -  Ideal weight: weight corresponding to a BMI = 25 kg/m2.&#xD;
&#xD;
        -  Excess weight lost (%): (Pre-BS weight - current weight)/excess weight [(pre- BS weight&#xD;
           - ideal weight) x 100].&#xD;
&#xD;
        -  Total weight lost (%): (pre-Bs weight - current weight/pre-BS weight) x 100.&#xD;
&#xD;
           b) To study WR the following variables will be calculated:&#xD;
&#xD;
        -  Total WR (%): (100/(pre-BS weight - weight at nadir)) * weight regained (kg).&#xD;
&#xD;
        -  Excess WR (EWR %): [(current weight - weight at nadir)/excess weight] x 100&#xD;
&#xD;
        -  Weight regained (Kg): current weight - weight at nadir.&#xD;
&#xD;
      Excess weight lost &gt; 50%, total weight lost &gt; 25% and EWR &gt; 15% will be considered as&#xD;
      significant.&#xD;
&#xD;
      Information regarding the psychological and behavioral variables will be collected using&#xD;
      questionnaires that have been validated in our setting and will be completed by the patients&#xD;
      themselves online.&#xD;
&#xD;
      To assess hedonic response to the foods, the following questionnaires will be used:&#xD;
&#xD;
        -  The subscale of external signal-triggered eating of the Dutch Eating Behavior&#xD;
           Questionnaire (DEBQ) that includes 10 questions.&#xD;
&#xD;
        -  A food addiction questionnaire (Yale Food Addiction Scale II) with 25 questions.&#xD;
&#xD;
        -  The Bulimia Investigatory Test Edinburgh (BITE) made up of 2 subscales of symptoms and&#xD;
           severity including 33 questions.&#xD;
&#xD;
        -  There will also be questions related to snacking/nibbling.&#xD;
&#xD;
      The following will be used to assess mood state, stress and negative emotions:&#xD;
&#xD;
        -  Dutch Eating Behavior Questionnaire (DEBQ) which evaluates eating styles and takes into&#xD;
           account 3 subscales: external, restrained (10), and emotional eating (13) including a&#xD;
           total of 23 questions.&#xD;
&#xD;
        -  Positive and Negative Affect Schedule (PANAS) to assess the positive and negative&#xD;
           effects of emotional experiences including 20 questions.&#xD;
&#xD;
        -  Barrat Impulsivity Scale (BIS-11) which evaluates impulsive tendencies in 3 dimensions:&#xD;
           cognitive, motor and lack of planning and includes 30 questions.&#xD;
&#xD;
        -  The consumption of toxic substances will be determined using the following&#xD;
           questionnaires: Alcohol Use Disorders Identification Test (AUDIT-4) including 4&#xD;
           questions in which data on the frequency and quantity of alcohol consumed will be&#xD;
           obtained, and the Fagerstr√∂m Nicotine Dependence Scale including 6 questions.&#xD;
&#xD;
        -  The Eysenck Personality Questionnaire - Revised (EPQ-R) with only the dimension of&#xD;
           neuroticism including 23 questions.&#xD;
&#xD;
      These variables will be considered as confounding psychological variables and will,&#xD;
      therefore, be controlled by statistical tests.&#xD;
&#xD;
        -  Depression: evaluated with the Hospital Anxiety and Depression Scale (HADS) including 14&#xD;
           questions.&#xD;
&#xD;
        -  Perceived economic status, assessed using a visual analog scale of 10 cms with markings&#xD;
           at 0, 5, 10 cm without numbers.&#xD;
&#xD;
        -  The International Physical Activity Questionnaire (IPAQ) including 7 questions to assess&#xD;
           physical activity.&#xD;
&#xD;
        -  Social support evaluated by the evaluation protocol using the English Longitudinal Study&#xD;
           of Aging study. APGAR (including 5 questions).&#xD;
&#xD;
        -  Quality of life evaluated using the Impact of Weight on the Quality of Life - Lite&#xD;
           (IWQOL-lite) questionnaire including 31 questions.&#xD;
&#xD;
      Evaluation of food intake: The patients will also complete a registry of foods and drinks&#xD;
      consumed over 3 days including a weekend day. It should include the type of food, cooking&#xD;
      method, and portion size or weight. Afterwards, the total intake and by macronutrients will&#xD;
      be analyzed with the Diet Source software (Nestle Health Science. V4.0).&#xD;
&#xD;
      Primary variable:&#xD;
&#xD;
      Body weight: total weight lost (%), excess weight lost (%), total weight regained (%), excess&#xD;
      of weight regain (%).&#xD;
&#xD;
      Data collection:&#xD;
&#xD;
      Additional information on demographic and anthropometric characteristics and on comorbidities&#xD;
      both prior to BS and their evolution over time will be collected in an Excel datasheet&#xD;
      designed with this objective.&#xD;
&#xD;
      Sample size The study will include 445 patients undergoing BS. It is estimated that the&#xD;
      percentage of losses to follow-up at 5 years will not be greater than 10% and thus, at least&#xD;
      400 patients must achieve complete follow-up. This sample size will have a statistical power&#xD;
      of 80% for detecting an effect size, that is, differences divided by the standard deviation&#xD;
      of at least 0.281. Additionally, 100 controls not undergoing BS will be included and matched&#xD;
      for age, gender and BMI with the objective of standardizing the values in the scales. The&#xD;
      ratio will be 1:4 for controls and patients undergoing BS, respectively.&#xD;
&#xD;
      Statistical analysis. The design and statistical analysis of the present study meet the&#xD;
      recommendations of consensus documents in the literature, especially the TRIPOD statement. A&#xD;
      statistical analysis plan (SAP) will be elaborated prior to finalization of data collection&#xD;
      and will provide an in-depth description of the statistical methods to be used, the tables&#xD;
      and figures that will be included in the statistical report as well as the strategy to follow&#xD;
      in the case of missing values, and multiplicity adapted to regulatory and scientific&#xD;
      recommendations.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 1, 2019</start_date>
  <completion_date type="Anticipated">September 1, 2026</completion_date>
  <primary_completion_date type="Anticipated">September 1, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Total weight lost percent (%).</measure>
    <time_frame>5 years.</time_frame>
    <description>Total weight lost &gt; 25 percent.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Excess weight lost: percent (%),</measure>
    <time_frame>5 years</time_frame>
    <description>Excess weight lost &gt; 50 percent</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Total weight regained: percent (%)</measure>
    <time_frame>5 years</time_frame>
    <description>Total weight regained &gt; 15%</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Excess of weight regain: percent (%).</measure>
    <time_frame>5 years</time_frame>
    <description>EWR &gt; 15 percent will be considered as significant</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">500</enrollment>
  <condition>Mental Health Issue</condition>
  <condition>Eating Behavior</condition>
  <arm_group>
    <arm_group_label>BS patients</arm_group_label>
    <description>Candidates to primary BS undergoing laparoscopic gastric bypass (LGBP) or laparoscopic sleeve gastrectomy (LSG) from September 2020 to September 2021. Patients will be evaluated prior to BS and at 4 months, 1, 3 and 5 years after BS.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>no BS patient</arm_group_label>
    <description>A control group of subjects with obesity not candidates to BS matched with the intervention group for age, sex and BMI prior to BS. Patients will be evaluated once.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Questionnaire</intervention_name>
    <description>Psychological and behavioral variables will be collected using questionnaires that have been validated in our setting and will be completed by the patients themselves online.</description>
    <arm_group_label>BS patients</arm_group_label>
    <arm_group_label>no BS patient</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Candidates to primary BS undergoing laparoscopic gastric bypass (LGBP) or laparoscopic&#xD;
        sleeve gastrectomy (LSG) from September 2020 to September 2021 and a control group of&#xD;
        subjects with obesity not candidates to BS matched with the intervention group for age, sex&#xD;
        and BMI prior to BS.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Candidate to primary BS from 09/2020 to 09/2021.&#xD;
&#xD;
          -  Subjects with obesity (&gt;40 kg/m2) not candidates to BS.&#xD;
&#xD;
          -  Internet users.&#xD;
&#xD;
          -  Primary BS: LGBP and LSG.&#xD;
&#xD;
          -  Accept to participate in the study and provide signed informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Second time and/or revisional BS.&#xD;
&#xD;
          -  Pregnancy.&#xD;
&#xD;
          -  Presence of intellectual impairment impeding the administration of the psychometric&#xD;
             tools.&#xD;
&#xD;
          -  Type 1 diabetes.&#xD;
&#xD;
          -  Dyslexia.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Lilliam Flores, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Obesity Unit, Endocrinology and Nutrition Department</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Lilliam Flores, PhD</last_name>
    <phone>0034658023562</phone>
    <email>lflores@clinic.cat</email>
  </overall_contact>
  <location>
    <facility>
      <name>Hospital Clinic</name>
      <address>
        <city>Barcelona</city>
        <zip>08036</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lilliam Flores, PhD</last_name>
      <phone>0034658023562</phone>
      <email>lflores@clinic.cat</email>
    </contact>
    <investigator>
      <last_name>Lilliam Flores, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>M Jos√© Barahona, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Marta Bueno, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Assumpta Caix√°s, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Ani de Hollande, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Albert Lecube, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Inka Mi√±ambres, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>M Jos√© Morales, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Rosa Mor√≠nigo, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Joana Nicolau, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Silvia Pellitero, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Javier Salvador, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Sergio Vald√©s, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Nuria Vilarrasa, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Diana Tundidor, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Romina Olbeyra, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>August 2020</verification_date>
  <study_first_submitted>May 8, 2020</study_first_submitted>
  <study_first_submitted_qc>August 24, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">August 26, 2020</study_first_posted>
  <last_update_submitted>August 24, 2020</last_update_submitted>
  <last_update_submitted_qc>August 24, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">August 26, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>GOSEEN Obesity group of the Spanish Endocrinology Society</investigator_affiliation>
    <investigator_full_name>Lilliam Flores</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>obesity</keyword>
  <keyword>eating behaviour</keyword>
  <keyword>weight regained</keyword>
  <keyword>bariatric surgery</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Body-Weight Trajectory</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>March 7, 2019</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/43/NCT04526743/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

